Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Imidacloprid; Moxidectin
Krka, d.d., Novo mesto
QP54AB52
Imidacloprid; Moxidectin
250,62.5 mg/pipette
Spot-on solution
POM: Prescription Only Medicine as defined in relevant national legislation
moxidectin, combinations
Authorised
2020-03-13
CONFIDENTIAL 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Imoxicate 250 mg/62.5 mg spot-on solution for large dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2.5 ml pipette contains: ACTIVE SUBSTANCES: Imidacloprid 250 mg Moxidectin 62.5 mg Butylhydroxytoluene (E 321) 2.5 mg Benzyl alcohol (E 1519) 2018 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Spot-on solution. Clear, slightly yellow to yellow or to brownish yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Large dogs (>10-25 kg). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For dogs suffering from, or at risk from, mixed parasitic infections: The treatment and prevention of flea infestation ( _Ctenocephalides felis_ ), The treatment of biting lice ( _Trichodectes canis_ ), The treatment of ear mite infestation ( _Otodectes cynotis_ ), sarcoptic mange (caused by _Sarcoptes _ _scabiei _ var. _canis_ ), demodicosis (caused by _Demodex canis_ ), The prevention of heartworm disease (L3 and L4 larvae of _Dirofilaria immitis_ ), Treatment of circulating microfilariae ( _Dirofilaria immitis_ ), The treatment of cutaneous dirofilariosis (adult stages of _Dirofilaria repens_ ), The prevention of cutaneous dirofilariosis (L3 larvae of _Dirofilaria repens_ ), The reduction of circulating microfilariae ( _Dirofilaria repens_ ), The prevention of angiostrongylosis (L4 larvae and immature adults of _Angiostrongylus vasorum_ ), The treatment of _Angiostrongylus vasorum _ and _Crenosoma vulpis_ , The prevention of spirocercosis ( _Spirocerca lupi_ ), The treatment of _Eucoleus _ (syn. _Capillaria_ ) _boehmi _ (adults), The treatment of the eye worm _Thelazia callipaeda _ (adults), Treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of _Toxocara canis, Ancylostoma caninum _ and _Uncinaria stenocephala_ , adults of _Toxascaris leonina _ and _Trichuris vulpis_ ). The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). 2 CONFIDENTIAL 4.3 CONTRAIND Belgenin tamamını okuyun